Research Labs

Our innovative research focuses on four areas:

  1. Basic research
  2. Next-generation therapeutics
  3. HIV prevention-vaccine development
  4. Passive administration of neutralizing antibodies and microbicides

  • Goff Lab

    The Goff lab studies the life cycle of retroviruses, and performs screens to identify and characterize restriction factors that inhibit virus replication and the host factors that they require.

  • Guo Lab

    The Guo Lab uses bioinformatics to study immune responses to pandemic and disease-related viruses, focusing on countermeasures for pandemic preparedness and antibody therapies for various diseases.

  • Ho Lab

    The Ho Lab is committed to finding scientific solutions to end the HIV/AIDS pandemic and using the techniques acquired in their decades of HIV research to the novel coronavirus SARS-CoV-2.

    David Ho and Yaoxing Huang

  • Huang Lab

    The Huang Lab devotes efforts to develop HIV vaccine and antibody-based strategies and long-acting antiretroviral drugs as pre-exposure prophylaxis to halt or slow the spread of AIDS.

  • Iketani Lab

    The Iketani Lab is focused on developing scalable strategies that contribute to answering basic and translational virology questions, particularly for pandemic preparedness and virological discovery.

  • Kwong-Shapiro Lab

    The Kwong-Shapiro Lab focuses on structural vaccinology to advance antibody therapeutics and vaccines. Their research has contributed to the design of vaccines against HIV-1, influenza A, and RSV.

    Jordan Becker, Nicholas Morano, Peter Kwong, Ryan Roark, Lawrence Shapiro in an office

  • Meyers Lab

    The Meyers lab addresses health inequity by accelerating translation of scientific discoveries into public health interventions accessible to marginalized populations, with a particular focus on HIV.

  • Sabo Lab

    The focus of the Sabo Lab is to expand our understanding of cellular host factors and their interaction with specific infecting viral pathogens: HIV-1 and the human respiratory syncytial virus (HRSV).

    Microscopic imagery of a cell

  • Sheng Lab

    The goal of the Sheng Lab is to use interdisciplinary approaches to understand the mechanisms of antibody maturation and disease etiology, and to find therapeutic targets for disease prevention.

  • Tsuji Lab

    The Tsuji Lab's research projects are applied and translational, seeking to further understanding of host immune system for development of effective vaccines against infectious diseases and cancer.

  • Yamashita Lab

    The Yamashita Lab studies the biology of human immunodeficiency virus to elucidate the fundamental principles of viral replication and to develop novel drug design strategies.